Stevanato Group SpA

STVN

Company Profile

  • Business description

    Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.

  • Contact

    Via Molinella 17
    Piombino Dese
    Padua35017
    ITA

    T: +39 49931811

    https://www.stevanatogroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2026

    Employees

    5,795

Stocks News & Analysis

stocks

Is this the catalyst US tech giant needs?

Muse models may just be the spark that the rirm needed in AI model development.
stocks

ASX share plunges due to Iran related weakness

Despite headwinds our long-term outlook is unchanged.
stocks

Investors punish this ASX player after acquisition

We think the floundering stock price is not reflective of underlying asset value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,113.406.400.07%
CAC 408,235.9823.62-0.29%
DAX 4023,742.4461.51-0.26%
Dow JONES (US)47,964.0147.440.10%
FTSE 10010,582.9617.57-0.17%
HKSE25,660.85232.69-0.90%
NASDAQ23,063.89160.990.70%
Nikkei 22556,502.77421.34-0.74%
NZX 50 Index13,020.18161.26-1.22%
S&P 5006,849.0432.150.47%
S&P/ASX 2008,926.0014.200.16%
SSE Composite Index3,988.562.330.06%

Market Movers